Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · IEX Real-Time Price · USD
11.53
-0.08 (-0.69%)
Jul 7, 2022 9:40 AM EDT - Market open
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | Current | 2021 |
|---|---|---|
| Market Capitalization
|
538 | 950 |
| Enterprise Value
|
223 | 598 |
| PE Ratio
|
- | -12.84 |
| PB Ratio
|
1.65 | 2.73 |
| Debt / Equity Ratio
|
0.02 | 0 |
| Debt / EBITDA Ratio
|
-0.08 | 0 |
| Debt / FCF Ratio
|
-0.09 | 0 |
| Current Ratio
|
25.65 | 20.96 |
| Return on Equity (ROE)
|
-24.50% | -29.20% |
| Return on Assets (ROA)
|
-23.40% | -22.80% |
| Return on Capital (ROIC)
|
-173.80% | -14100.70% |
| Earnings Yield
|
-15.91% | -7.79% |
| FCF Yield
|
-15.23% | -7.27% |
| Buyback Yield / Dilution
|
-2626.13% | -1548.09% |
| Total Shareholder Return
|
-2626.13% | -1548.09% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).